| |
| |
|
| Insider
Information: |
Alpern Robert J |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
204,163 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,572,252 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
204,163 |
|
|
| Total
Value |
$9,572,252 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
|
2024-04-26 |
39,163 |
2009-04-24 |
0 |
Premium* |
|
|
Abbvie Inc. |
ABBV |
|
2023-09-07 |
33,121 |
2013-05-06 |
0 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director |
2022-11-21 |
131,879 |
2018-07-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABT |
Abbott Laboratories |
|
– • – |
2024-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,866 |
39,163 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
|
– • – |
2023-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
129 |
33,121 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,450 |
32,992 |
0 |
- |
|
| ABT |
Abbott Laboratories |
|
– • – |
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,816 |
37,297 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2022-11-21 |
4 |
S |
$0.23 |
$6,344 |
D/D |
(27,584) |
131,879 |
0 |
% |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,421 |
31,542 |
0 |
- |
|
| ABT |
Abbott Laboratories |
|
– • – |
2022-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,602 |
35,481 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,403 |
159,463 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2021-05-07 |
4 |
A |
$115.96 |
$194,929 |
D/D |
1,681 |
30,121 |
0 |
- |
|
| ABT |
Abbott Laboratories |
|
– • – |
2021-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,499 |
33,879 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,670 |
143,060 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
28,440 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Director |
– • – |
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,974 |
32,380 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-20 |
4 |
AS |
$40.65 |
$99,145 |
D/D |
(2,439) |
138,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-12 |
4 |
AS |
$39.92 |
$46,267 |
D/D |
(1,159) |
140,829 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-07 |
4 |
AS |
$39.93 |
$157,843 |
D/D |
(3,953) |
141,988 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-06 |
4 |
AS |
$39.75 |
$9,023 |
D/D |
(227) |
145,941 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-05 |
4 |
AS |
$39.89 |
$64,023 |
D/D |
(1,605) |
146,168 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-11-04 |
4 |
AS |
$39.84 |
$104,261 |
D/D |
(2,617) |
147,773 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-10-25 |
4 |
AS |
$36.29 |
$401,739 |
D/D |
(11,000) |
150,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-09-26 |
4 |
AS |
$30.76 |
$31,440 |
D/D |
(1,000) |
161,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-08-26 |
4 |
AS |
$33.19 |
$33,190 |
D/D |
(1,000) |
162,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-07-25 |
4 |
AS |
$31.60 |
$31,600 |
D/D |
(1,000) |
163,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-07-03 |
4 |
AS |
$37.05 |
$111,150 |
D/D |
(3,000) |
164,390 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,879 |
167,390 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
